详情页 - 河北大学附属医院知识库

资源类型：

文章类型：

作者：

Chen, Gongyan[1] * ; Wang, Xiang[2] ; Liu, Yunpeng[3] ; Wu, Lin[4] ; Hao, Yanrong[5] ; Liu, Chunling[6] ; Zhu, Shuyang[7] ; Zhang, Xiaodong[8] ; Li, Yuping[9] ; Liu, Jiwei[10] ; Cao, Lejie[11] ; Cheng, Ying[12] ; Zhao, Hui[13] ; Zhang, Shucai[14] ; Zang, Aimin[15]

; Cui, Jiuwei[16] ; Feng, Jian[17] ; Liu, Fei[18] ; Gu, Chuan[19] ; Shi, Yuankai[19] ;

机构： [1]Harbin Med Univ Canc Hosp, Dept Resp, Harbin, Peoples R China [2]Xuzhou Cent Hosp, Xuzhou, Jiangsu, Peoples R China [3]First Hosp China Med Univ, Med Oncol, Shenyang, Peoples R China [4]Cent South Univ, Hunan Canc Hosp, Affiliated Canc Hosp Xiangya Sch Med, Dept Thorac Med, Changsha, Peoples R China [5]Guangxi Zhuang Autonomous Reg Peoples Hosp, Nanning, Peoples R China [6]Affiliated Tumor Hosp Xinjiang Med Univ, Urumqi, Peoples R China [7]Affiliated Hosp Xuzhou Med Coll, Xuzhou, Jiangsu, Peoples R China [8]Canc Hosp Nantong, Dept Med Oncol, Nantong, Peoples R China [9]First Affiliated Hosp Wenzhou Med Univ, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China [10]First Affiliated Hosp Dalian Med Univ, Dalian, Peoples R China [11]Anhui Prov Hosp, Dept Resp & Crit Care Med, Hefei, Peoples R China [12]Jilin Canc Hosp, Dept Med Thorac Oncol, Changchun, Peoples R China [13]Second Hosp Anhui Univ, Dept Resp Med, Hefei, Peoples R China [14]Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China [15]Affiliated Hosp Hebei Univ,North Hosp,Dept Oncol,Baoding,Peoples R China [16]First Hosp Jilin Univ, Changchun, Peoples R China [17]Affiliated Hosp Nantong Univ, Nantong, Peoples R China [18]Shanghai Allist Pharmaceut Technol Co Ltd, Shanghai, Peoples R China [19]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2022]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Harbin Med Univ Canc Hosp, Dept Resp, Harbin, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Central nervous system efficacy of furmonertinib versus gefitinib in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: Results from FURLONG study

文献详情